News | Ultrasound Imaging | September 09, 2022

A combination of performance and versatility, the V7 is optimized to conquer challenging clinical cases in a busy ultrasound environment with accuracy and precision

The V7 ultrasound system delivers a multi-faceted diagnostic experience to imaging professionals across hospital departments – aiding clinician performance and patient care

September 9, 2022 — Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound business, introduces the V7; a cutting-edge ultrasound system that provides a wide range of clinical applications that enhance both the patient and user experience. The V7 recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use.

“There is a continued demand on imaging professionals to deliver high-quality results in an efficient amount of time, without compromising patient care,” said David Legg, Vice President, Head of Boston Imaging. “We’re proud to help address this by supplying one more solution that helps make clinical assessments effortless and treatment precise.”

Crystal Architecture is the core of the V7’s enhanced image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

Samsung continuously works to provide healthcare professionals with innovative solutions made to conquer diverse and challenging cases. To help assist, the V7 is equipped with a range of Intelligent Assist features to be used in both general imaging and women’s health ultrasound cases, including:

  • 2D Follicle: An automated measurement tool that provides information about the status of follicles during gynecology examinations by identifying and measuring follicle size based on the 2D image.
  • AutoIMT: A screening tool to analyze a patient's potential risk for cardiovascular disease.
  • S-Shearwave Imaging: A tool that provides quantitative non-invasive assessment and documentation of tissue stiffness for clinical applications including breast and liver.
  • UterineAssist: An Artificial Intelligence technology that automatically measures the size and shape of the uterus, assisting in detecting signs of uterine-related abnormalities.
  • E-Cervix: An innovative elastography technology that provides an efficient semi-quantitative assessment of cervical canal stiffness.

In addition to enhancing image clarity and accuracy, the V7 design has been reengineered, keeping workflow, performance, and functionality top of mind. Tools such as EzExam+ and EzCompare may transform the ultrasound examination experience through the minimization of steps and keystrokes. The V7 also exhibits a step forward in Samsung’s efforts toward a greener tomorrow, by applying an eco-friendly resin cover to the air vent exterior cover and reusable Eco Paper Packaging composed of recycled paper.

For more information: http://news.samsung.com


Related Content

News | Information Technology

July 20, 2026 — GE HealthCare has introduced MIM Anyware, a remote access platform that provides secure, healthcare ...

Time July 20, 2026
arrow
News | ACR

July 15, 2026 — The American College of Radiology (ACR) recently issued a statement praising the inclusion of the ...

Time July 16, 2026
arrow
News | Cardiac Imaging

July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...

Time July 15, 2026
arrow
News | PET Imaging

July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...

Time July 15, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
Feature | X-Ray | Kyle Hardner

Water-window X-rays allow researchers to visualize biological cells at high contrast without staining agents or other ...

Time June 23, 2026
arrow
Subscribe Now